Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings

Human Immunology

Volumn 73, Issue 11, 2012, Pages 1116-1126

  Svensson, Jannet ^a   Eising, Stefanie ^b   Hougaard, David Michael ^c   Mortensen, Henrik Bindesbøl ^a   Skogstrand, Kristin ^c   Simonsen, Lars Bjarke ^d   Carstensen, Bendix ^d   Nilsson, Anita ^e   Lernmark, Åke ^e   Pociot, Flemming ^e,f,g   Johannesen, Jesper ^a  

^a Mental Health Services CPH   (Denmark)

^b Sønderborg Hospital   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d STENO DIABETES CENTER   (Denmark)

^e LUND UNIVERSITY   (Sweden)

^f GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIABETIC PATIENT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SIBLING; SUMMER; TH1 CELL; TH2 CELL;

ADOLESCENT; AGE FACTORS; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT; INSULIN; MALE; SEASONS; SEX FACTORS; SIBLINGS; TH1 CELLS; TH2 CELLS; TIME FACTORS;

EID: 84867847451     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.337     Document Type: Article

References (43)

1. Eurodiab ACE study group: variation and trends in incidence of childhood diabetes in Europe. Eurodiab ACE study group. Lancet 2000;355:873-6.
2. Gale E.A. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002, 51:3353-3361.
3. Yan H., Takamoto M., Sugane K. Exposure to Bisphenol A prenatally or in adulthood promotes T(H)2 cytokine production associated with reduction of CD4CD25 regulatory T cells. Environ Health Perspect 2008, 116:514-519.
4. Silveira P.A., Grey S.T. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends Endocrinol Metab 2006, 17:128-135.
5. Panagiotopoulos C., Trudeau J.D., Tan R. T-cell epitopes in type 1 diabetes. Curr Diab Rep 2004, 4:87-94.
6. Rabinovitch A., Suarez-Pinzon W.L. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes. Cell Biochem Biophys 2007, 48:159-163.
7. Nerup J., Mandrup-Poulsen T., Helqvist S., Andersen H.U., Pociot F., Reimers J.I., et al. On the pathogenesis of IDDM. Diabetologia 1994, 37(Suppl. 2):S82-S89.
8. Karlsson M.G., Lawesson S.S., Ludvigsson J. Th1-like dominance in high-risk first-degree relatives of type I diabetic patients. Diabetologia 2000, 43:742-749.
9. Hussain M.J., Maher J., Warnock T., Vats A., Peakman M., Vergani D. Cytokine overproduction in healthy first degree relatives of patients with IDDM. Diabetologia 1998, 41:343-349.
10. Kallmann B.A., Lampeter E.F., Hanifi-Moghaddam P., Hawa M., Leslie R.D., Kolb H. Cytokine secretion patterns in twins discordant for type I diabetes. Diabetologia 1999, 42:1080-1085.
11. Rabinovitch A., Suarez-Pinzon W.L. Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rev Endocr Metab Disord 2003, 4:291-299.
12. Bergholdt R., Heding P., Nielsen K., Nolsoe R., Sparre T., Storling J., et al. Type 1 database mellitus: an inflammatory disease of the islet. Adv Exp Med Biol 2004, 552:129-153.
13. Svensson J., Lyngaae-Jorgensen A., Carstensen B., Simonsen L.B., Mortensen H.B. Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time. Pediatr Diabetes 2009, 10:248-254.
14. Skogstrand K., Thorsen P., Nørgaard-Pedersen B., Schendel D.E., Sørensen L.C., Hougaard D.M. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 2005, 51:1854-1866.
15. Lynch K.F., Lernmark B., Merlo J., Cilio C.M., Ivarsson S.A., Lernmark A. Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype. J Perinatol 2008, 28:211-217.
16. Hermann R., Knip M., Veijola R., Simell O., Laine A.P., Akerblom H.K., et al. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes: indication of an increased environmental pressure?. Diabetologia 2003, 46:420-425.
17. Resic-Lindehammer S., Larsson K., örtqvist E., Carlsson A., Cederwall E., Cilio C., et al. The Swedish childhood diabetes study group: temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk. Acta Diabetol 2008, 231-235.
18. Hussain M.J., Peakman M., Gallati H., Lo S.S., Hawa M., Viberti G.C., et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 1996, 39:60-69.
19. Cavallo M.G., Pozzilli P., Bird C., Wadhwa M., Meager A., Visalli N., et al. Clin Exp Immunol 1991, 256-259.
20. Espersen G.T., Mathiesen O., Grunnet N., Jensen S., Ditzel J. Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following initial insulin treatment. APMIS 1993, 101:703-706.
21. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993, 90:770-774.
22. Christ M., Cartney-Francis N.L., Kulkarni A.B., Ward J.M., Mizel D.E., Mackall C.L., et al. Immune dysregulation in TGF-beta 1-deficient mice. J Immunol 1994, 153:1936-1946.
23. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
24. von Herrath M., Sanda S., Herold K. Type 1 diabetes as a relapsing-remitting disease?. Nat Rev Immunol 2007, 7:988-994.
25. Nicoletti F., Conget I., Di Mauro M., Di Mauro R., Mazzarino M., Bendtzen K., et al. Serum concentrations of the interferon-?-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 2002, 45:1107-1110.
26. Hanifi-Moghaddam P., Schloot N.C., Kappler S., Seissler J., Kolb H. An association of autoantibody status and serum cytokine levels in type 1 diabetes. Diabetes 2003, 52:1137-1142.
27. Shames R.S. Gender differences in the development and function of the immune system. J Adolesc Health 2002, 30:59-70.
28. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2001, 2:777-780.
29. Whitacre C.C., Reingold S.C., O'Looney P.A., Blankenhorn E., Brinley F., Collier E., et al. Biomedicine: a gender gap in autoimmunity. Science 1999, 283:1277-1278.
30. Gilmore W., Weiner L.P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997, 158:446-451.
31. Duramad P., Tager I.B., Holland N.T. Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol Lett 2007, 172:48-59.
32. Damsgaard C.T., Lauritzen L., Kjaer T.M.R., Holm P.M.I., Fruekilde M.B., Michaelsen K.F., et al. Fish oil supplementation modulates immune function in healthy infants. J Nutr 2007, 137:1031-1036.
33. Hannet I., Erkeller-Yuksel F., Lydyard P., Deneys V., De Bruyere M. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 1992, 13:215-218.
34. Holland N., Dong J., Garnett E., Shaikh N., Huen K., Harmatz P., et al. Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn's disease and age-related changes in Th1/Th2 cytokine profiles. Pediatr Res 2008, 63:257-262.
35. Balic I., Angel B., Codner E., Carrasco E., Pèrez-Bravo F. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Hum Immunol 2009, 70:116-120.
36. Douglas S., McSporran B., Smail P. Seasonality of presentation of type I diabetes mellitus in children. Scott Med J 1999, 44:41-46.
37. D'Ambrosio D., Cippitelli M., Cocciolo M.G., Mazzeo D., Di L.P., Lang R., et al. Inhibition of IL-12 production by 1, 25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998, 101:252-262.
38. Penna G., Adorini L. 1{Alpha}, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000, 164:2405-2411.
39. Mathieu C., Gysemans C., Giulietti A., Bouillon R. Vitamin D and diabetes. Diabetologia 2005, 48:1247-1257.
40. Khoo A.L., Chai L.Y., Koenen H.J., Sweep F.C., Joosten I., Netea M.G., et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 2011, 164:72-79.
41. Skogstrand K., Ekelund C.K., Thorsen P., Vogel I., Jacobsson B., Nørgaard-Pedersen B., et al. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods 2008, 336:78-84.
42. Vedder H., Schreiber W., Yassouridis A., Gudewill S., Galanos C., Pollmacher T. Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm Res 1999, 48:67-74.
43. Chervonsky AV. Intestinal commensals: influence on immune system and tolerance to pathogens. Curr Opin Immunol. 2012.